SK BIOPHARMACEUTICALS
SK biopharmaceuticals aims to become a top tier specialty pharmaceutical company with global new drugs & innovative pipeline in CNS / metabolic disorders and to provide world class specialized pharmaceutical manufacturing services.
SK BIOPHARMACEUTICALS
Industry:
Biotechnology Manufacturing Therapeutics
Founded:
2011-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.skbp.com
Total Employee:
51+
Status:
Active
Contact:
82 2 2121 0110
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apache Mobile Non Scaleable Content Microsoft Azure DNS GlobalSign AlphaSSL Softlayer
Similar Organizations
Mits lifesciences
Pharmaceuticals company
SRM INDIA
Pharmaceutical Company
Investors List
Korea Drug Development Fund
Korea Drug Development Fund investment in Seed Round - SK biopharmaceuticals
Official Site Inspections
http://www.skbp.com Semrush global rank: 3.69 M Semrush visits lastest month: 3.76 K
- Host name: 6b.66.38a9.ip4.static.sl-reverse.com
- IP address: 169.56.102.107
- Location: Seongnam-si South Korea
- Latitude: 37.4388
- Longitude: 127.1396
- Timezone: Asia/Seoul
- Postal: 13332
More informations about "SK biopharmaceuticals"
SK Biopharmaceuticals - skbp.com
A fully integrated global pharmaceutical company, SK BiopharmaceuticalsSee details»
Ethical management System < Ethical Management - skbp.com
Business Ethics & Practices In 2023, SK Biopharmaceuticals was recognized for outstanding efforts in the area of business ethics & practices relative to global peers in pharmaceutical …See details»
Board of Directors < Governance < Investors < SK …
Introducing Board Skills Matrix (BSM) The SK Biopharmaceuticals Board of Directors responds to the needs of various stakeholders, including shareholders, investors, and the market, by …See details»
Global Leader in the Development of New Drugs - SK
SK Biopharmaceuticals is pioneering the research and development of innovative drugs treating cancers and central nervous system disorders.See details»
SK biopharmaceuticals
SK biopharmaceuticals was formed in 1993 when SK Group, one of Korea's largest conglomerates, began exploring the research and development of new drugs as a driver of …See details»
SK biopharmaceuticals - Crunchbase Company Profile & Funding
SK biopharmaceuticals announced that 100,000 patients globally have been treated with Cenobamate through sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and …See details»
SK Biopharmaceuticals - LinkedIn
SK Biopharmaceuticals has been leading the development of new innovative drugs targeting the global market. We aim to grow into a fully integrated global pharmaceutical company (global …See details»
SK Biopharmaceuticals - Company Profile & Staff Directory
SK Biopharmaceuticals is a part of the global conglomerate SK Group, the second largest company in Korea. We’re responsible for the development of innovative next-generation drugs …See details»
SK BioUSA 2024
SK bioscience is a leading vaccine and bio company committed to promoting human health from prevention to cure with its globally-competitive R&D capabilities, cutting-edge production facilities and 1000+experts.See details»
Overview < Company < SK Biopharmaceuticals
SK Biopharmaceuticals leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide. We have independently developed …See details»
SK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals Co., Ltd.)
了解SK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals Co., Ltd.)公司的药物管线，治疗领域，技术平台，以及它的50项临床试验, 54篇新闻和32篇文献，疾病领域:神经系统疾病，肿 …See details»
SK Biopharmaceuticals Overview | SignalHire Company Profile
SK Biopharmaceuticals is a part of the global conglomerate SK Group, the second largest company in Korea. We’re responsible for the development of innovative next-generation drugs …See details»
SK Biopharmaceuticals Enters Greater China Out-Licensing 6 …
SK Biopharmaceuticals Enters Greater China Out-Licensing 6 Clinical Pipelines to CNS-Focused Biotech Ignis Therapeutics SK Biopharmaceuticals enters into agreement to out-license a …See details»
SK Biopharmaceuticals’ Cenobamate Demonstrates Clinical …
Dec 10, 2024 In October, 2020, Ono Pharmaceutical Co., Ltd. entered into an exclusive license agreement with SK Biopharmaceuticals (SKBP) for the development and commercialization of …See details»
Scientific Advisory Board < Company < SK Biopharmaceuticals
“With global authorities, SK Biopharmaceuticals' Scientific Advisory Board provides scientific insights to strengthen R&D expertise and new drug development competitiveness and build …See details»
SK Bio-pharm Tech (Shanghai) Co., Ltd. - Drug pipelines, Patents ...
Explore SK Bio-pharm Tech (Shanghai) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
ZERO | Project for epilepsy
Dec 10, 2022 Project ZERO provides relief to those living with epilepsy. ZERO can monitor your biosignals in real - time to alert you and your caregiver of an oncoming seizure. Plus, ZERO …See details»
SK Biopharmaceuticals Becomes First Korean Company to Join ...
Feb 24, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced today that it has joined the Pharmaceutical Supply Chain...See details»
SK바이오팜
SK바이오팜은 '빅 바이오텍'으로 도약하는 글로벌 혁신 신약 개발 기업입니다.See details»
SK Biopharmaceuticals的Cenobamate在韩国、中国和日本的癫痫 …
Dec 10, 2024 小野制药有限公司与SK Biopharmaceuticals之间的许可协议：2020年10月，小野制药有限公司与SK Biopharmaceuticals（SKBP）签订了独家许可协议，用于开发和商业 …See details»